BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 1347920)

  • 1. [Alpha interferon treatment in hairy cell leukemia].
    Hagberg H
    Nord Med; 1992; 107(3):74-5. PubMed ID: 1347920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of hairy cell leukemia: an update.
    Golomb HM; Ratain MJ; Mick R; Daly K
    Leukemia; 1992; 6 Suppl 2():24-7. PubMed ID: 1349662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hairy cell leukemia and its treatment with 2-chlorodeoxyadenosine (2-CdA)].
    Pawelski S
    Acta Haematol Pol; 1995; 26(2):139-43. PubMed ID: 7653218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hairy-cell leukaemia: first-line treatment with cladribine or pentostatin.
    Prescrire Int; 2006 Aug; 15(84):143-4. PubMed ID: 16989031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
    Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
    Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hairy cell leukemia: evaluation of the long-term outcome in 121 patients.
    Zinzani PL; Pellegrini C; Stefoni V; Derenzini E; Gandolfi L; Broccoli A; Argnani L; Quirini F; Pileri S; Baccarani M
    Cancer; 2010 Oct; 116(20):4788-92. PubMed ID: 20597132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia.
    Med Lett Drugs Ther; 1992 Sep; 34(879):89-90. PubMed ID: 1355592
    [No Abstract]   [Full Text] [Related]  

  • 8. Hairy cell leukaemia: review of treatment.
    Kurzrock R; Talpaz M; Gutterman JU
    Br J Haematol; 1991 Oct; 79 Suppl 1():17-20. PubMed ID: 1718389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine).
    Füreder W; Weltermann A; Chott A; Gisslinger H; Valent P; Jäger U; Geissler K; Lechner K
    Wien Klin Wochenschr; 1999 Dec; 111(24):1027-30. PubMed ID: 10677889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab: a useful drug for a repeatedly relapsed hairy cell leukemia patient.
    Pollio F; Pocali B; Palmieri S; Morabito P; Scalia G; Del Vecchio L; Ferrara F
    Ann Hematol; 2002 Dec; 81(12):736-8. PubMed ID: 12483372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine.
    Piro LD; Carrera CJ; Carson DA; Beutler E
    N Engl J Med; 1990 Apr; 322(16):1117-21. PubMed ID: 1969613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study.
    Johnston JB; Eisenhauer E; Wainman N; Corbett WE; Zaentz SD; Daeninck PJ
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):32-6. PubMed ID: 10877049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hairy cell leukemia: treatment successes in the past 25 years.
    Golomb HM
    J Clin Oncol; 2008 Jun; 26(16):2607-9. PubMed ID: 18509168
    [No Abstract]   [Full Text] [Related]  

  • 14. [A new effective therapy of hairy cell leukemia and other lymphoproliferative diseases].
    Juliusson G; Liliemark J
    Lakartidningen; 1991 Aug; 88(35):2746-9. PubMed ID: 1680209
    [No Abstract]   [Full Text] [Related]  

  • 15. Hairy-cell leukemia and alpha-interferon treatment: long-term responders.
    Zinzani PL; Lauria F; Salvucci M; Rondelli D; Raspadori D; Bendandi M; Magagnoli M; Tura S
    Haematologica; 1997; 82(2):152-5. PubMed ID: 9175317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hairy-cell leukemia: current views.
    Tallman MS; Peterson LC; Hakimian D; Gillis S; Polliack A
    Semin Hematol; 1999 Apr; 36(2):155-63. PubMed ID: 10319384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hairy cell leukaemia, its therapy and prognosis (historical review with own experiences).
    Chrobák L; Podzimek K; Zak P; Plísková L; Voglová J
    Acta Haematol Pol; 1995; 26(2 Suppl 1):56-62. PubMed ID: 7653236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of interferon in patients with hairy cell leukemia and myeloproliferative disorders].
    Skotnicki AB; Wolska-Smoleń T
    Acta Haematol Pol; 1994; 25(2 Suppl 1):124-35. PubMed ID: 8067197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hairy cell leukemia successfully treated with 2'-deoxycoformycin following refractoriness to splenectomy and alpha-interferon therapy].
    Shibata T; Hotta T
    Rinsho Ketsueki; 1992 Feb; 33(2):216-20. PubMed ID: 1635172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of hairy-cell leukemia using interferon alfa].
    Neuwirtová R; Cermák J; Kvasnicka J; Sedlácková M
    Cas Lek Cesk; 1989 Aug; 128(34):1065-70. PubMed ID: 2790914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.